TRAVERE THERAPEUTICS, INC. (TVTX) Total liabilities 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) total liabilities at each fiscal year-end, per SEC filings.
$490.4MFY2025 · since FY2016: $217.5M → $490.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $490.4M | -8.4% |
| FY2024 | $535.0M | -9.0% |
| FY2023 | $588.1M | -6.6% |
| FY2022 | $629.7M | +32.7% |
| FY2021 | $474.5M | +19.8% |
| FY2020 | $396.2M | +3.3% |
| FY2019 | $383.6M | -1.9% |
| FY2018 | $390.9M | +72.0% |
| FY2017 | $227.2M | +4.5% |
| FY2016 | $217.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice